Compile Data Set for Download or QSAR
Report error Found 52 Enz. Inhib. hit(s) with all data for entry = 10888
TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576361(WO2022112205, Example 16)
Affinity DataIC50: 575nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576354(WO2022112205, Example 11)
Affinity DataIC50: 594nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576361(WO2022112205, Example 16)
Affinity DataIC50: 660nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576349(WO2022112205, Example 5)
Affinity DataIC50: 688nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576349(WO2022112205, Example 5)
Affinity DataIC50: 750nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576354(WO2022112205, Example 11)
Affinity DataIC50: 823nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576355(WO2022112205, Example 12)
Affinity DataIC50: 891nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576358(WO2022112205, Example 13)
Affinity DataIC50: 950nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576358(WO2022112205, Example 13)
Affinity DataIC50: 995nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576357(WO2022112205, Example 12-b)
Affinity DataIC50: 1.01E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576345(WO2022112205, Example 2-a)
Affinity DataIC50: 1.19E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576369(WO2022112205, Example 7)
Affinity DataIC50: 1.21E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576356(WO2022112205, Example 12-a)
Affinity DataIC50: 1.30E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576369(WO2022112205, Example 7)
Affinity DataIC50: 1.31E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576348(WO2022112205, Example 4)
Affinity DataIC50: 1.32E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576350(WO2022112205, Example 6)
Affinity DataIC50: 1.37E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576355(WO2022112205, Example 12)
Affinity DataIC50: 1.52E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576343(WO2022112205, Example 1 | WO2022112205, Example 9)
Affinity DataIC50: 1.77E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576366(WO2022112205, Example 21)
Affinity DataIC50: 1.87E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576346(WO2022112205, Example 2-b)
Affinity DataIC50: 1.89E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576350(WO2022112205, Example 6)
Affinity DataIC50: 2.02E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576344(WO2022112205, Example 2)
Affinity DataIC50: 2.14E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576343(WO2022112205, Example 1 | WO2022112205, Example 9)
Affinity DataIC50: 2.17E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576357(WO2022112205, Example 12-b)
Affinity DataIC50: 2.19E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576362(WO2022112205, Example 17)
Affinity DataIC50: 2.19E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576356(WO2022112205, Example 12-a)
Affinity DataIC50: 2.23E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576367(WO2022112205, Example 22)
Affinity DataIC50: 2.33E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576345(WO2022112205, Example 2-a)
Affinity DataIC50: 2.38E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576366(WO2022112205, Example 21)
Affinity DataIC50: 2.60E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576364(WO2022112205, Example 19)
Affinity DataIC50: 2.61E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576353(WO2022112205, Example 10)
Affinity DataIC50: 2.67E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576348(WO2022112205, Example 4)
Affinity DataIC50: 2.81E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576367(WO2022112205, Example 22)
Affinity DataIC50: 3.00E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576364(WO2022112205, Example 19)
Affinity DataIC50: 3.23E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576362(WO2022112205, Example 17)
Affinity DataIC50: 3.25E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576360(WO2022112205, Example 15)
Affinity DataIC50: 3.31E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576359(WO2022112205, Example 14)
Affinity DataIC50: 3.56E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576346(WO2022112205, Example 2-b)
Affinity DataIC50: 3.64E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576363(WO2022112205, Example 18)
Affinity DataIC50: 3.70E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576347(WO2022112205, Example 3)
Affinity DataIC50: 3.83E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576365(WO2022112205, Example 20)
Affinity DataIC50: 4.28E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576353(WO2022112205, Example 10)
Affinity DataIC50: 4.44E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576360(WO2022112205, Example 15)
Affinity DataIC50: 4.76E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576363(WO2022112205, Example 18)
Affinity DataIC50: 4.96E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576359(WO2022112205, Example 14)
Affinity DataIC50: 5.18E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576343(WO2022112205, Example 1 | WO2022112205, Example 9)
Affinity DataIC50: 5.37E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576344(WO2022112205, Example 2)
Affinity DataIC50: 6.45E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetExternal core antigen(HBVgbn)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576365(WO2022112205, Example 20)
Affinity DataIC50: 7.21E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576347(WO2022112205, Example 3)
Affinity DataIC50: 8.05E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

TargetLarge envelope protein(HBV-D)
F. Hoffmann-La Roche

WIPO
LigandPNGBDBM576351(WO2022112205, Example 8)
Affinity DataIC50: 9.04E+3nMAssay Description: Detailed procedures regarding primary human hepatocyte (PHH) HBV natural infection assay are described as below. One tube of frozen PHH (10 million ...More data for this Ligand-Target Pair
In DepthDetails
WIPO WO2022112205

Displayed 1 to 50 (of 52 total ) | Next | Last >>
Jump to: